|
PubHealth.info®
(a subsidiary of
PakMed) presents scientific information mainly
based on abstracts of articles published on a variety of public health issues/topics,
particularly encompassing
population planning, disease prevention, maternal and child health,
and communicable and
non-communicable diseases (like HIV AIDS, malaria, etc) that are
affecting a significant portion of population in developing and
developed
countries. Here you can find abstracts of articles published on a variety of public health
topics under category "Contraception
(Birth Control) and Family Planning".
Contraception (birth control)
is a regimen of one or more actions, devices, or medications followed in
order to deliberately prevent or reduce the likelihood of a woman
becoming pregnant or giving birth. Therefore contraception is the
utilization of various and sundry surgical procedures, devices,
practices, agents, or drugs with the intention of preventing conception
or impregnation (pregnancy). Methods and intentions typically termed
birth control may be considered a pivotal ingredient to family
planning. Birth control is a controversial political and ethical
issue in many cultures and religions, and although it is generally less
controversial than abortion specifically. |
|
|
| CATEGORY: |
Contraception (Birth Control) and Family Planning |
| Risk of thrombosis with oral contraceptives -- si tacuisses (letter) |
| [Thromboserisiko oraler Kontrazeptiva - si tacuisses.] |
| ZENTRALBLATT FUR GYNAKOLOGIE. 1996;118(12):697-9. |
| A criticism is presented about an editorial by RDT Farmer on the alleged risk of thromboembolism caused by the |
| third generation oral contraceptives (OCs), gestoden and desogestrel. A number of factors were not taken into |
| consideration when coming to the conclusion that the latest generation OCs pose an increased risk of |
| thromboembolism. The studies cited to support his position in fact prove the opposite, and different preparations |
| containing gestagens are not compared. The debate rages around the common sense of attributing significantly |
| increased risk on the basis of an increase of thromboembolism from 2 cases per 10,000 users per year among |
| second generation OC users to 4 cases per 10,000 users per year among third generation OC users. The author |
| admits that the risk is very minuscule. Bias also enters the picture on account of confounding by indication, the fact |
| that the physician decides on the basis of prognosis, perception, expectation, and the disease, which all exert a |
| direct effect on the choice of treatment. In addition, the health user effect also has an influence. This was |
| recognized at an international congress in Amsterdam in August 1996. The great problem was bias, which was also |
| treated in Science, the organ of the American Academy of Sciences. Furthermore, in Great Britain the product |
| information of gestoden-containing preparations states that thromboembolitic episodes are less frequent than with |
| the old OCs and they also exert fewer side effects on the metabolism. The Austrian experts have always maintained |
| that the problem of thromboembolism is not caused by the new preparations, but rather by faulty prescribing. |
| (PubHealth.info Document ID: CONT2T 2077-06) |
| PubHealth.info NOTE: The author(s) of this article titled, "Risk of thrombosis with oral contraceptives -- si tacuisses |
| (letter) [Thromboserisiko oraler Kontrazeptiva - si tacuisses.]", is(are) Huber JC. The source of this article is |
| "ZENTRALBLATT FUR GYNAKOLOGIE. 1996;118(12):697-9.". This article was published in 1996 in German |
| language(s). (PubHealth.info® Document ID: CONT2T 2077-06. All rights reserved with PubHealth.info) PIN: 7077 |
|
|
|
© Copyrights PubHealth.info®,
an information portal on public health. All rights
reserved.
This page is optimized to be viewed by
Java script enabled Microsoft®
Internet Explorer 6 or later version, at screen resolution of 800 by 600 pixels. |